Neuropeptide Y Deficiency in Bone Marrow Drives Blood Stem Cell Aging and Dysfunction | Research

The takeaway

NPY deficiency in the bone marrow microenvironment drives hematopoietic stem cell aging, promoting inflammation-biased differentiation and impaired blood cell production.

Peptide controls stem cell aging
NPY in bone marrow keeps blood stem cells young — its loss drives the immune decline associated with aging

What the researchers found

Bone marrow NPY deficiency drives HSC aging with inflammation-biased differentiation and impaired hematopoiesis, revealing NPY as a niche-dependent regulator of blood stem cell function.

Why it matters

Aging immune decline affects everyone. Understanding that NPY maintains young blood stem cells could lead to interventions preventing immune aging.

How the study worked

Studies of NPY-deficient bone marrow microenvironment effects on HSC function, differentiation bias, aging markers, and hematopoietic output.

What this study cannot tell us

Preclinical. Human bone marrow NPY regulation may differ. Cannot distinguish local vs systemic NPY effects.

How to read the evidence

Preclinical mechanistic study. Novel neuro-immune-stem cell connection.

When this study was published

Published in 2025.

The bigger picture

Neuropeptides don't just signal in the brain — NPY in bone marrow controls blood stem cell aging, connecting the nervous and immune systems at the stem cell level.

Questions still open

Could NPY supplementation rejuvenate aging bone marrow?
Is bone marrow NPY decline a biomarker for immune aging?
Would exercise (which increases NPY) improve HSC function in elderly?

Common questions

How does a brain peptide affect blood cells?

NPY is produced in bone marrow (not just the brain) where it keeps blood stem cells functioning youthfully. When NPY declines with age, stem cells shift toward producing inflammatory cells instead of balanced blood production.

Could this lead to anti-aging treatments?

Potentially. If NPY levels in bone marrow can be maintained or restored, it might preserve healthy immune function during aging — essentially keeping the blood and immune system younger.

Read the original research

Neuropeptide Y deficiency in the bone marrow drives hematopoietic stem and progenitor cell aging.

bioRxiv : the preprint server for biology

View on PubMed ↗Publisher’s paper ↗

Citation

Kamble, Dinisha; Ropa, James P; Kamocka, Malgorzata M; Qi, Yan; Imperiale, Nick; Singh, Pratibha. (2026). Neuropeptide Y deficiency in the bone marrow drives hematopoietic stem and progenitor cell aging.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.02.20.706987